Celularity Unveils Promising Placenta-Derived NK Cell Therapy to Combat Aging and Senescent Cells
May 23, 2024Celularity presented new data on their placenta-derived NK cell therapy program.
The therapy shows potential as senolytic agents to target and eliminate senescent cells.
CEO Dr. Robert Hariri highlights the natural effectiveness of NK cells in clearing out damaged cells.
The company leverages the biological properties of the placenta for various age-related diseases.
NK cells could potentially change aging biology by clearing out senescent cells and introducing new cells.
Celularity is seeking collaborative partners to advance their work in cellular senescence and age-related degenerative changes.
The company aims to revolutionize aging biology through their innovative approach.
Summary based on 1 source
Get a daily email with more Science stories
Source
Longevity.Technology - Latest News, Opinions, Analysis and Research • May 23, 2024
Natural killer cells: harnessing Nature’s senolytic